NDC 0944-2705-05 - GAMMAGARD Liquid ERC
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0944-2705
- Requested NDC
- 0944-2705-05
- Package NDCs from labels
- 0944-2705-05, 0944-2705-50, 0944-2705-01, 0944-2705-10
- Manufacturer
- Takeda Pharmaceuticals America, Inc. | Baxalta Belgium Manufacturing SA
- Effective date
- 2025-10-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| GAMMAGARD Liquid ERC - Takeda Pharmaceuticals America, Inc. | Baxalta Belgium Manufacturing SA | Takeda Pharmaceuticals America, Inc. | Baxalta Belgium Manufacturing SA | 2025-10-30 | PLASMA DERIVATIVE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0944-2705-01 | GAMMAGARD Liquid ERC | 100 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 100 | 2 | |
| 0944-2705-05 | GAMMAGARD Liquid ERC | 50 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 50 | 2 | |
| 0944-2705-10 | GAMMAGARD Liquid ERC | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 2 | |
| 0944-2705-50 | GAMMAGARD Liquid ERC | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0944-2705-01 | ML - Milliliter | 0944-2705 | 2403e9f7-0713-4629-bd51-a369088b63f3 | 1 | 2026-02-05 |
| 0944-2705-05 | ML - Milliliter | 0944-2705 | e51d96de-7f1e-49c2-bafe-96275aee3752 | 1 | 2026-02-05 |
| 0944-2705-10 | ML - Milliliter | 0944-2705 | 83beec54-eb27-4517-863d-087112d68859 | 1 | 2026-02-05 |
| 0944-2705-50 | ML - Milliliter | 0944-2705 | b4397ffd-e0fb-4d4b-9251-cd50b1d7eeb0 | 1 | 2026-02-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ASCENIV | HUMAN IMMUNOGLOBULIN G | ADMA Biologics, Inc. | d74f4360-3b51-496c-96fb-84c3976958d2 | 2026-09-29 | Boxed warning, Warnings, Adverse reactions | 66Y330CJHS |
| BIVIGAM | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10% | ADMA Biologics, Inc. | a2244aa0-a6d0-11df-b385-0002a5d5c51b | 2026-09-29 | Boxed warning, Warnings, Adverse reactions | 1809421 1809414 66Y330CJHS |
| TrophAmine | ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, CYSTEINE HYDROCHLORIDE, HISTIDINE, TYROSINE, N-ACETYL-TYROSINE, ALANINE, ARGININE, PROLINE, SERINE, GLYCINE, ASPARTIC ACID, GLUTAMIC ACID, AND TAURINE | B. Braun Medical Inc. | cb6d23ff-3ec5-445a-acbe-f88fd57949bf | 2026-08-19 | Warnings, Adverse reactions | TE7660XO1C |
| YIMMUGO | IMMUNE GLOBULIN INTRAVENOUS, HUMAN - DIRA | Kedrion Biopharma Inc | 50fc5ffc-49aa-51f2-e063-6294a90a59cf | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | 66Y330CJHS |
| HYQVIA | IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE | Takeda Pharmaceuticals America, Inc. | 7ca2c26f-4be2-48cd-be5b-486e350654ba | 2026-06-18 | Boxed warning, Warnings, Adverse reactions | 1809421 1809414 |
| Plenamine | LYSINE ACETATE, LEUCINE, PHENYLALANINE, VALINE, ISOLEUCINE, METHIONINE, THREONINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, HISTIDINE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID, AND TYROSINE | B. Braun Medical Inc. | a3244d1a-45b0-4e4c-bd96-f0632d761a1f | 2026-05-08 | Warnings, Adverse reactions | TE7660XO1C |
| Privigen | HUMAN IMMUNOGLOBULIN G | CSL Behring AG | 7e5649da-75be-4a42-8eeb-4aeba562c401 | 2026-05-04 | Boxed warning, Warnings, Adverse reactions | 1809421 1809414 66Y330CJHS |
| AKSO N2 Youth Complex Essence | ARGININE PYROGLUTAMATE, COLEUS FORSKOHLII, GLUTAMINE, GLYCINE, MUCUNA PRURIENS, ORNITHINE ALPHA-KETOGLUTARATE, DIOSCOREA VILLOSA, TYROSINE | HEALWAY | 5028304b-22b4-c191-e063-6394a90a5525 | 2026-04-23 | Warnings | TE7660XO1C |
| YIMMUGO | IMMUNE GLOBULIN INTRAVENOUS, HUMAN - DIRA | Biotest AG | 77aaac18-f2af-46c4-8f65-b15be1cec3c2 | 2026-03-01 | Boxed warning, Warnings, Adverse reactions | 66Y330CJHS |
| QIVIGY kthm | HUMAN IMMUNOGLOBULIN G | Kedrion S.p.A. | 6f1933e0-240f-48f4-b246-8a30e63a4160 | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | 66Y330CJHS |
| GAMMAGARD Liquid | IMMUNE GLOBULIN INFUSION (HUMAN) | Takeda Pharmaceuticals America, Inc. | 9d42adca-0dd7-4df7-864d-5a7feee52130 | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | BLA125105 1809421 1809414 66Y330CJHS |
| CUVITRU | IMMUNE GLOBULIN SUBCUTANEOUS (HUMAN) | Takeda Pharmaceuticals America, Inc. | 9aad7ec9-6097-4805-8f1b-898bec35f218 | 2025-11-25 | Boxed warning, Warnings, Adverse reactions | 66Y330CJHS |
| Aminosyn II | ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, HISTIDINE, PROLINE, SERINE, N-ACETYLTYROSINE, AND GLYCINE | ICU Medical Inc. | 5b426208-f090-4650-86c3-89040ba45c2d | 2025-11-02 | Boxed warning, Warnings, Adverse reactions | TE7660XO1C |
| GAMMAGARD Liquid ERC | IMMUNE GLOBULIN INFUSION (HUMAN) | Takeda Pharmaceuticals America, Inc. | 1341fd31-0754-47f0-a4d6-7255056b6541 | 2025-10-30 | Boxed warning, Warnings, Adverse reactions | BLA125105 0944-2705-05 0944-2705-50 0944-2705-10 0944-2705-01 0944-2705 00944270505 2733847 1809421 1809414 2733845 2332ff1f-1311-4aaa-9d76-9a011b3f7956 1341fd31-0754-47f0-a4d6-7255056b6541 66Y330CJHS |
| Gammaplex | HUMAN IMMUNOGLOBULIN G | Bio Products Laboratory Ltd | 2098af41-aec7-4af7-98bb-54f8ab55f30e | 2025-10-23 | Boxed warning, Warnings, Adverse reactions | 1809421 1809414 66Y330CJHS |
| Glycine | GLYCINE | ICU Medical Inc. | c10a4657-cf64-4a71-a247-363dd58993bc | 2025-10-21 | Warnings, Adverse reactions | TE7660XO1C |
| Aminosyn-PF | ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, GLYCINE, HISTIDINE, PROLINE, SERINE, TAURINE, AND TYROSINE | ICU Medical Inc. | 2d212e10-7e08-4aeb-b63f-dcc927897769 | 2025-10-17 | Warnings, Adverse reactions | TE7660XO1C |
| Aminosyn-PF | ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, GLYCINE, HISTIDINE, PROLINE, SERINE, TAURINE, AND TYROSINE | ICU Medical Inc. | 46e74ce4-cd7e-437f-bf54-ca9b98eb2663 | 2025-10-10 | Boxed warning, Warnings, Adverse reactions | TE7660XO1C |
| Perikabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | c2eb5522-8572-45f4-869d-42f9fd251bb6 | 2025-09-15 | Warnings, Adverse reactions | TE7660XO1C |
| Kabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | afeb4837-a759-4484-a76e-e04611c459e7 | 2025-09-11 | Warnings, Adverse reactions | TE7660XO1C |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.